Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Plc Gsk currently holds 0 shares of Theravance Biopharma, Inc. (TBPH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Plc Gsk has been a net neutral trader of TBPH stock. They have purchased $0 and sold $0 worth of shares.
Plc Gsk's most recent insider trade was on Sep 16, 2022, when they sold 9,644,807 shares at $9.75 per share.
Plc Gsk serves as Executive at Theravance Biopharma, Inc. (TBPH). They have executed 1 insider transactions totaling $0 over their tenure at the company.
Plc Gsk holds the position of Executive at Theravance Biopharma, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
Plc Gsk has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Plc Gsk was on Sep 16, 2022, when they sold $94.0M worth of TBPH shares. This transaction involved 9,644,807 shares at $9.75 per share.
Plc Gsk currently owns 0 shares of Theravance Biopharma, Inc. (TBPH), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Plc Gsk's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Plc Gsk has 1 Form 4 filings on record as an insider at Theravance Biopharma, Inc..
Set alerts for Plc Gsk and 40,000+ other insiders.